Thromboprophylaxis for children hospitalized with COVID‐19 and MIS

Por um escritor misterioso

Descrição

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
How we approach thrombosis risk in children with COVID-19 infection - Authorea
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
A guide to immunotherapy for COVID-19
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Frontiers Therapeutic Strategies for COVID-19 Lung Disease in Children
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
ASH Guidelines on Use of Anticoagulation in Patients with COVID-19
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C - ScienceDirect
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review - Frontiers
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Preventing Life-Threatening Blood Clots in Children with Serious Cases of COVID-19
de por adulto (o preço varia de acordo com o tamanho do grupo)